1. Home
  2. CRUS vs ICUCW Comparison

CRUS vs ICUCW Comparison

Compare CRUS & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRUS
  • ICUCW
  • Stock Information
  • Founded
  • CRUS 1984
  • ICUCW N/A
  • Country
  • CRUS United States
  • ICUCW United States
  • Employees
  • CRUS N/A
  • ICUCW 12
  • Industry
  • CRUS Semiconductors
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRUS Technology
  • ICUCW Health Care
  • Exchange
  • CRUS Nasdaq
  • ICUCW Nasdaq
  • Market Cap
  • CRUS N/A
  • ICUCW N/A
  • IPO Year
  • CRUS 1989
  • ICUCW 2021
  • Fundamental
  • Price
  • CRUS $109.07
  • ICUCW $0.03
  • Analyst Decision
  • CRUS Strong Buy
  • ICUCW
  • Analyst Count
  • CRUS 6
  • ICUCW 0
  • Target Price
  • CRUS $133.33
  • ICUCW N/A
  • AVG Volume (30 Days)
  • CRUS 903.1K
  • ICUCW N/A
  • Earning Date
  • CRUS 02-04-2025
  • ICUCW N/A
  • Dividend Yield
  • CRUS N/A
  • ICUCW N/A
  • EPS Growth
  • CRUS 75.79
  • ICUCW N/A
  • EPS
  • CRUS 5.50
  • ICUCW N/A
  • Revenue
  • CRUS $1,843,448,000.00
  • ICUCW N/A
  • Revenue This Year
  • CRUS $1.85
  • ICUCW N/A
  • Revenue Next Year
  • CRUS $3.90
  • ICUCW N/A
  • P/E Ratio
  • CRUS $19.85
  • ICUCW N/A
  • Revenue Growth
  • CRUS 2.99
  • ICUCW N/A
  • 52 Week Low
  • CRUS $81.30
  • ICUCW N/A
  • 52 Week High
  • CRUS $147.46
  • ICUCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • CRUS 58.31
  • ICUCW N/A
  • Support Level
  • CRUS $100.77
  • ICUCW N/A
  • Resistance Level
  • CRUS $113.14
  • ICUCW N/A
  • Average True Range (ATR)
  • CRUS 4.10
  • ICUCW 0.00
  • MACD
  • CRUS 0.80
  • ICUCW 0.00
  • Stochastic Oscillator
  • CRUS 77.25
  • ICUCW 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: